Showing 1,861 - 1,880 results of 74,822 for search '(( 50 ((ms decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (mean decrease)) ))', query time: 1.35s Refine Results
  1. 1861

    rVλ6Wil fibrils cause a decrease in cardiomyocytes MTT reduction without inducing cell death. by Helen P. McWilliams-Koeppen (116503)

    Published 2015
    “…(C) Cell number, quantified using crystal violet (black) did not decrease over 72 h of incubation with 1 μM rVλ6Wil fibrils despite a decrease in MMT reduction (grey; n = 3 samples per time point). …”
  2. 1862
  3. 1863
  4. 1864
  5. 1865

    Decreased diaphragm muscle axonal branching distance, bifurcations and neuromuscular junctions in GAD67-deficient (−/−) E18.5 mice. by Matthew J. Fogarty (283288)

    Published 2013
    “…C and D show significant decreases in the number of medial and lateral axonal branches (mean ± SEM) respectively at discrete distances away from main nerve trunk in GAD67-deficient (red) mice compared to wild type controls (blue). …”
  6. 1866
  7. 1867

    Mean SARS-CoV-2 viral load log 10 between groups. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log<sub>10</sub> within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”
  8. 1868
  9. 1869
  10. 1870
  11. 1871
  12. 1872
  13. 1873
  14. 1874
  15. 1875
  16. 1876
  17. 1877
  18. 1878
  19. 1879
  20. 1880

    Participant and lab results flow. by Gad Murenzi (6243719)

    Published 2025
    “…High-risk HPV prevalence was 25.5% [95% confidence interval (CI)=24.3%−26.8%] and the prevalence decreased with older ages and higher CD4 counts (p<sub>trend</sub><0.001 for both). …”